Exudative vitreoretinopathy 6 is a rare inherited eye disorder that affects how the blood vessels at the edge of the retina develop. Early signs of Exudative vitreoretinopathy 6 can include poor vision, a lazy eye, crossed eyes, or no obvious problems at first. Not everyone will have the same experience. Exudative vitreoretinopathy 6 is usually recognized in infancy, childhood, or sometimes later, and it is often lifelong. Treatment aims to protect vision and may include regular eye exams, laser treatment, freezing treatment, surgery, or low vision support, while the effect on sight and long-term outlook can range from mild to severe.
How many people live with Exudative vitreoretinopathy 6?
Exudative vitreoretinopathy 6 is a very rare inherited eye condition and one subtype of familial exudative vitreoretinopathy, but published sources do not provide a reliable worldwide count or a reliable U.S. count for this specific subtype, and the broader condition is also not consistently counted in the same way across sources (Orphanet, 2024; Genetic and Rare Diseases Information Center, 2024). In short, there is no single authoritative estimate for how many people are living with exudative vitreoretinopathy 6 worldwide or in the United States.
Overview
Exudative vitreoretinopathy 6Symptoms
Exudative vitreoretinopathy 6 can affect blood vessel growth in the retina. Signs may include poor vision, a wandering eye, or white pupils. In some babies and children, retinal scarring or detachment can lead to vision loss.
Outlook and prognosis
Exudative vitreoretinopathy 6 often changes slowly, but vision can worsen over time if the retina pulls, leaks, or detaches. With regular retinal care and timely treatment, many people with exudative vitreoretinopathy 6 keep useful sight longer.
Causes and risk factors
Exudative vitreoretinopathy 6 is caused by a gene change that disrupts normal retinal blood vessel development, usually inherited from a parent but sometimes new in the child. The main risk factor is a family history of the condition.
Genetic influences
Genetics are very important in exudative vitreoretinopathy 6, because it is usually caused by a change in the ZNF408 gene. These genetic variations can run in families and may help explain why eye findings and early symptoms of exudative vitreoretinopathy 6 vary so much.
Diagnosis
Exudative vitreoretinopathy 6 is diagnosed from eye exam findings, often supported by retinal imaging. The genetic diagnosis of Exudative vitreoretinopathy 6 uses genetic tests to confirm the cause, especially when clinical features suggest it.
Treatment and drugs
Care focuses on protecting sight with regular retina checks. Exudative vitreoretinopathy 6 may be treated with laser or freezing therapy to seal abnormal vessels. Some people also need eye injections or surgery for bleeding, scarring, or retinal detachment.
Symptoms
Vision changes can be very mild or quite serious, and the two eyes are often affected differently. In Exudative vitreoretinopathy 6, the blood vessels in the retina, the light-sensitive layer at the back of the eye, do not develop in the usual way. Some people have no obvious problems at first, so early features of Exudative vitreoretinopathy 6 may only be found during a detailed eye exam. When sight is affected, many living with Exudative vitreoretinopathy 6 may notice trouble seeing clearly, missing things off to the side, or changes in eye alignment.
Some people with Exudative vitreoretinopathy 6 see well at first and do not notice anything unusual day to day. The condition may be picked up only when an eye doctor examines the edges of the retina or screens family members.
Sharp vision can be reduced if the retina is pulled out of shape or affected by leaking fluid. This can make reading, schoolwork, driving, or recognizing faces harder.
Peripheral vision may be narrowed, so doorframes, steps, or people approaching from the side are easier to miss. In children, this may show up as clumsiness rather than a clear complaint about vision.
One eye may drift inward or outward when the brain relies more on the stronger eye. This is often easier for family members to spot in babies and young children than for the child to describe.
How people usually first notice Exudative vitreoretinopathy 6?
How exudative vitreoretinopathy 6 is first noticed can vary, but many families first learn something is wrong when a baby or child does not seem to track faces or objects normally, has a wandering eye, or seems to have reduced vision during early eye exams. In some children, the first signs of exudative vitreoretinopathy 6 are found by an eye doctor rather than at home, when the retina at the edge of the eye is seen to have developed abnormally and may show leaking, scarring, or even partial retinal detachment. Because severity can range from mild to serious, some people are diagnosed only after a sibling is found to have the condition or after genetic testing prompted by a family history.
Types of Exudative vitreoretinopathy 6
No distinct types of Exudative vitreoretinopathy 6 are widely recognized.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes or medicines can meaningfully delay the start of symptoms in exudative vitreoretinopathy 6, because it is an inherited eye condition that affects how the light-sensitive tissue at the back of the eye develops. Healthy habits like good sleep, exercise, and not smoking support overall eye and body health, but they have not been shown to prevent this condition or push back when it begins; what does help is regular care with an eye specialist so changes can be found early and treated if needed to protect vision. That may not change when the condition starts, but early follow-up can still make a real difference for many living with it.
What genetics can tell you about symptoms
In exudative vitreoretinopathy 6, genetics can sometimes help explain why eye problems vary so much from one person to another, even within the same family. Changes in the gene linked to this condition can affect how the retina’s blood vessels develop, which may influence whether someone has mild vision changes found on an eye exam or more serious problems such as poor vision, retinal bleeding, or retinal detachment, and symptoms can begin in childhood or later depending on the person. Even so, the same genetic change does not always cause the same symptoms in every family member, so genetics gives useful clues but cannot predict the exact course for one individual.
Causes and risk factors
In exudative vitreoretinopathy 6, the main cause is a change in the KIF11 gene, which helps blood vessels grow normally in the retina. This change can be passed down from a parent or can happen for the first time in a child. Other genes and small differences in eye development may affect how early symptoms of exudative vitreoretinopathy 6 appear and how severe they become. Risk can vary widely from person to person. No clear lifestyle or environmental exposure is known to cause exudative vitreoretinopathy 6, but ongoing eye checks are still important because the condition can worsen over time.
What are the most common causes or risk factors?
Exudative vitreoretinopathy 6 is mainly caused by an inherited change in a gene called ZNF408, which affects how blood vessels develop in the retina, the light-sensing layer at the back of the eye. The biggest risk factor is a family history of this condition or related early retinal problems, because it can run in families. There are no well-established lifestyle, diet, or environmental risk factors known to cause this specific type.
Environmental and biological risk factors
When people ask about risk factors for exudative vitreoretinopathy 6, the honest answer is that clear environmental or noninherited biological triggers have not been identified. This rare eye condition is usually linked to factors already present very early in development, rather than to exposures later in pregnancy, birth, or daily life. Because it is uncommon, research on outside risk factors is also limited.
At this time, no clear link has been proven between exudative vitreoretinopathy 6 and outside exposures such as radiation, heavy metals, air pollution, or common chemicals. These are not recognized causes or established environmental risk factors for the condition.
Mother’s health conditions, infections, or medication exposures during pregnancy have not been shown to specifically raise the chance of exudative vitreoretinopathy 6. If a pregnancy had complications, doctors usually look for other explanations rather than treating these as known causes of this condition.
Prematurity, low birth weight, and delivery-related stress are not established risk factors for exudative vitreoretinopathy 6. This matters because some eye findings can overlap with problems seen in babies born early, but the conditions are not caused in the same way.
Because exudative vitreoretinopathy 6 is rare, studies on body-based and environmental risk factors are limited. For now, doctors generally say there are no well-proven noninherited risk factors beyond what is present from very early development.
Genetic risk factors
Exudative vitreoretinopathy 6 usually happens because of a change in the KIF11 gene, which helps guide normal development of the retina and its blood vessels. This is mainly a genetic condition, not one caused by day-to-day choices. Carrying a genetic change doesn’t guarantee the condition will appear, because eye findings can vary a lot even within the same family. A family history of retinal disease, unexplained poor vision from childhood, or retinal detachment can raise concern even before the condition is recognized.
KIF11 changes: Exudative vitreoretinopathy 6 is most often caused by a harmful change in the KIF11 gene. When this gene does not work as it should, blood vessels in the retina may not develop normally.
Autosomal dominant inheritance: This condition is usually passed down in an autosomal dominant pattern, which means one altered copy of KIF11 can be enough to cause it. If a parent carries the change, each child has a 1 in 2, or 50%, chance of inheriting it.
Family history: Having a parent or close relative with Exudative vitreoretinopathy 6 or a known KIF11 change increases the genetic risk. A careful family history can be helpful when early symptoms of Exudative vitreoretinopathy 6 have not been noticed yet.
New gene change: Some people with Exudative vitreoretinopathy 6 are the first in their family to have the KIF11 change. In these cases, the change happened newly in them and was not inherited from either parent.
Variable expression: People with the same KIF11 change can have very different eye problems, from mild changes found on an exam to severe vision loss. This can make the inherited risk less obvious in some families.
Lifestyle risk factors
Exudative vitreoretinopathy 6 is an inherited retinal disorder, so lifestyle habits do not cause it. Still, how lifestyle affects exudative vitreoretinopathy 6 can matter because certain habits may influence eye strain, injury risk, treatment follow-up, and the chance of complications that worsen vision. The most helpful focus is on protecting the retina, supporting overall vascular health, and avoiding behaviors that could delay care when new symptoms appear.
Smoking does not cause exudative vitreoretinopathy 6, but it can harm retinal blood vessels and increase oxidative stress in eye tissues. That may add strain to an already vulnerable retina and may raise the risk of worse visual outcomes over time.
High-impact exercise, heavy straining, and activities with a risk of head or eye trauma may increase the chance of vitreoretinal traction or retinal complications in susceptible eyes. Safer, lower-impact physical activity can support general health without adding as much mechanical stress to the retina.
Poor control of blood pressure through inactivity, excess alcohol use, or a high-salt eating pattern can place extra stress on delicate retinal vessels. Good cardiovascular habits may help limit added vascular burden in people living with this condition.
Diet does not cause the disease, but a pattern low in fruits, vegetables, and omega-3-rich foods may offer less support against oxidative stress and inflammation. A balanced diet may help support overall eye health and recovery around treatments, even though it cannot reverse the genetic disorder.
Risk prevention
Exudative vitreoretinopathy 6 is a genetic eye condition, so there is no proven way to prevent the condition itself from being inherited or starting. Prevention is mainly about lowering the chance of vision problems by finding retinal changes early, treating complications quickly, and protecting overall eye health. Because severity can differ a lot, even within the same family, different people need different prevention strategies—there’s no single formula.
If exudative vitreoretinopathy 6 is known or suspected in a family, genetic counseling and family eye screening can help identify relatives who may need follow-up. This cannot stop the condition from existing, but it can catch silent retinal changes before they threaten sight.
Regular dilated retinal exams are one of the most important ways to reduce the risk of vision loss from exudative vitreoretinopathy 6. Babies, children, and adults in affected families may need checks even if they seem to see well day to day.
Early treatment of leaking blood vessels, retinal pulling, or areas with poor blood supply may help prevent more serious damage. Depending on what the eye doctor finds, this may include laser treatment, injections, or surgery.
New flashes, floaters, blurry vision, loss of side vision, or a curtain-like shadow need urgent medical attention. These can be warning signs of retinal detachment, which is one of the most serious complications and may follow early symptoms of exudative vitreoretinopathy 6.
Can you prevent Exudative vitreoretinopathy 6?
No, there is no known way to prevent exudative vitreoretinopathy 6, because it is an inherited eye condition that happens when the retina, the light-sensitive tissue at the back of the eye, does not develop its blood vessels normally. If it runs in your family, family planning advice and early eye checks for relatives may help find problems sooner and reduce the risk of vision loss, but they cannot prevent the condition itself.
Transmission
Exudative vitreoretinopathy 6 is not infectious, so it does not spread from person to person through touch, the air, blood, food, or sex. Instead, it is a genetic eye condition, so how Exudative vitreoretinopathy 6 is inherited matters more than exposure.
The genetic transmission of Exudative vitreoretinopathy 6 is usually autosomal dominant, which means a child can develop it if they inherit one changed copy of the gene from either parent; if a parent carries that change, each pregnancy has a 1 in 2, or 50%, chance of passing it on. In some families, the gene change happens for the first time in the child, so Exudative vitreoretinopathy 6 can appear even when no one else in the family is known to have it.
When to test your genes
Consider genetic testing if you or your child has signs of familial exudative vitreoretinopathy, such as abnormal retinal blood vessel development, retinal folds, or detachment, especially in infancy or childhood. Testing also helps when there is a family history, because relatives may need early eye exams even if symptoms are mild or absent.
Diagnosis
Exudative vitreoretinopathy 6 is usually diagnosed after an eye doctor notices problems in the retina, often in a baby, child, or young adult with reduced vision, a wandering eye, or a retina that has pulled away. Getting a diagnosis is often a turning point toward answers and support. Because signs can range from very mild to severe, the diagnosis of Exudative vitreoretinopathy 6 often combines a detailed eye exam with retinal imaging and genetic testing.
Doctors examine the back of the eye with dilating drops to look for areas where the outer retina did not develop normal blood vessels. They also check for scarring, bleeding, fluid leakage, or retinal detachment, which can happen in Exudative vitreoretinopathy 6.
Wide-field retinal photos and scans help show the far edges of the retina, where changes may be easy to miss on a routine exam. These imaging findings can document abnormal vessels, pulling on the retina, or detached areas and help guide treatment decisions.
A fluorescein angiogram uses a small amount of dye in a vein to show how blood flows through the retinal vessels. It can reveal areas with poor blood supply or leaking vessels, which are important clues in how Exudative vitreoretinopathy 6 is diagnosed.
Optical coherence tomography, often called OCT, uses light waves to create detailed cross-section images of the retina. It can show swelling, scar tissue, or traction that may not be obvious during the exam alone.
How is Exudative vitreoretinopathy 6 diagnosed?
Exudative vitreoretinopathy 6 is usually diagnosed by an eye doctor during a careful dilated eye exam, looking at the retina, the light-sensitive layer at the back of the eye, to see whether its blood vessels developed normally. Pictures and scans of the back of the eye, sometimes using a special dye to show blood flow, help find areas of poor blood supply, leaking, scar tissue, or pulling on the retina. Because this condition can run in families, doctors also ask about family history, and a genetic test may be used to confirm the exact inherited type after the eye findings suggest the diagnosis.
Stages of Exudative vitreoretinopathy 6
Exudative vitreoretinopathy 6 can affect the retina in a step-by-step way, although the pace and severity can vary a lot from one person to another. Some people have few symptoms for years, while others develop vision problems earlier in life. Early and accurate diagnosis helps you plan ahead with confidence. Doctors often use eye exams and retinal imaging to look for the early symptoms of Exudative vitreoretinopathy 6 and track whether the condition is changing.
Stage 1
The outer edge of the retina has areas where blood vessels have not developed fully. Vision may still seem normal, and many living with Exudative vitreoretinopathy 6 have no obvious day-to-day symptoms at this stage.
Stage 2
Abnormal blood vessels and scar-like changes can begin to form near the poorly developed retina. Some may notice blurred vision, reduced vision in one eye, or changes picked up only during an eye exam.
Stage 3
Part of the retina starts to pull away, which is called a retinal detachment. For many, this can mean shadows, distorted vision, or a sudden drop in sight, especially if the center of vision becomes involved.
Stage 4
A larger retinal detachment develops, but the very center of the retina may still remain attached. Vision is often clearly affected, and prompt specialist care is usually needed to try to protect remaining sight.
Stage 5
The retina is completely detached. This is the most advanced stage and can cause severe vision loss or blindness in the affected eye.
Outlook and prognosis
The outlook for exudative vitreoretinopathy 6 is highly variable, ranging from mild peripheral retinal changes with stable vision to progressive disease with retinal exudation, traction, detachment, and substantial vision loss. Prognosis is generally better when the condition is recognized early and monitored closely, because timely laser treatment, anti-VEGF therapy, or vitreoretinal surgery may help preserve vision in selected cases. Even with treatment, some people develop recurrent or worsening retinal complications over time, so long-term ophthalmic follow-up is important. Visual outcomes often differ between affected family members and even between the two eyes of the same person. This disorder is not known to shorten life expectancy, and mortality is not considered increased as a direct result of the eye disease itself.
Long-term effects
For many living with exudative vitreoretinopathy 6, the long-term picture centers on how much the retina is affected and whether changes stay stable or worsen over time. Vision can remain fairly good in some people, while others develop lasting sight problems that affect reading, driving, schoolwork, or moving around in dim light. Long-term effects vary widely, even within the same family, because one eye may be much more affected than the other. Early symptoms of exudative vitreoretinopathy 6 can be subtle, so some long-term changes are only recognized after vision has already been affected.
Lasting blurred or reduced vision is one of the main long-term effects, especially if the central retina becomes involved. Some people have mild limits, while others have more significant vision loss that does not fully recover.
One eye may stay stronger while the other has much poorer vision. Over time, this difference can affect depth perception and make tasks like catching a ball, using stairs, or parking a car harder.
Long-term pulling, scarring, or folding of the retina can change how clearly images are focused. In more severe cases, these structural changes can lead to permanent visual impairment.
Some people develop partial or complete retinal detachment, where the light-sensing layer lifts away from the back of the eye. This can cause major, sometimes sudden, long-term loss of sight if the damage is extensive.
How is it to live with Exudative vitreoretinopathy 6?
Living with exudative vitreoretinopathy 6 can mean living with very different levels of vision, from mild trouble with depth perception or night vision to major sight loss if the retina becomes damaged or detaches. In daily life, many people need regular eye appointments, quick attention to new symptoms such as flashes, floaters, or a curtain-like shadow in vision, and practical adjustments for reading, school, work, driving, or moving safely in dim light. This can also affect the people around you, because family members may help with transportation, watch for sudden vision changes, and adapt home, school, or work routines, but with close follow-up and the right visual supports, many people build stable and active lives.
Treatment and drugs
Treatment for exudative vitreoretinopathy 6 depends on how much the retina is affected, and in mild cases it may mainly involve regular eye exams to watch for changes before vision is harmed. When abnormal blood vessels start leaking or pulling on the retina, doctors may treat the eye with laser therapy or freezing treatment to seal those areas and lower the risk of scarring or retinal detachment. If the retina has already detached, surgery may be needed to repair it and protect as much sight as possible. Doctors sometimes recommend a combination of lifestyle changes and drugs, but for exudative vitreoretinopathy 6, medicines usually play a smaller role than eye procedures, though some people may be considered for injections that reduce abnormal vessel growth. Finding the right therapy can take some time, especially because early symptoms of exudative vitreoretinopathy 6 can be subtle and treatment plans often change with age, vision, and exam findings.
Can you cure Exudative vitreoretinopathy 6?
No, exudative vitreoretinopathy 6 cannot currently be cured. Treatment cannot fix the underlying genetic cause, but regular care from an eye specialist can help manage problems in the back of the eye and may help protect vision with close monitoring, medicines, laser treatment, or sometimes surgery. Because it can change over time and affect people differently, ongoing follow-up is important.
Non-drug treatment
Care for exudative vitreoretinopathy 6 often centers on protecting sight, keeping the retina attached, and helping people make the most of the vision they have. Treatment is tailored to how much of the retina is affected, whether there is leakage or scarring, and whether vision problems are already present. Supportive therapies can also help with reading, school, work, and daily tasks when vision is reduced. Because changes in the retina may worsen quietly, regular follow-up with a retina specialist is a key part of care.
Regular dilated eye exams and retinal imaging help doctors watch for new leaking blood vessels, pulling on the retina, or areas where the retina is starting to lift. This can matter even when day-to-day vision seems stable, because problems may develop before you notice symptoms.
Laser can seal off peripheral areas of retina that are not getting enough blood flow and lower the drive for abnormal vessel growth. Early treatment for exudative vitreoretinopathy 6 may use laser when doctors see high-risk changes before a retinal detachment develops.
Cryotherapy uses controlled freezing on the outside of the eye to treat abnormal retinal tissue when laser is hard to apply. It is used less often than laser, but it can still be helpful in selected cases.
If the retina has detached or is being pulled out of place by scar tissue, surgery may be needed to relieve traction and try to reattach it. Depending on the problem, this can involve a vitrectomy, a scleral buckle, or both.
Your genes may have an impact on how drugs work for you
For exudative vitreoretinopathy 6, there is no well-established proof that the gene change causing the condition also changes how most commonly used medicines work. In practice, care is usually guided more by what is happening in the eye, such as bleeding or abnormal blood vessel growth, than by gene-based medicine matching. As research grows, this may become clearer, but right now genetic testing for this condition is mainly used to confirm the diagnosis and help with family planning, not to choose medications.
Pharmacological treatments
Medication is not usually the main treatment for Exudative vitreoretinopathy 6, because doctors often rely more on procedures such as laser treatment, freezing treatment, or surgery when the retina is at risk. In some cases, eye specialists may use injected medicines to help control leaking blood vessels or abnormal vessel growth. Not everyone responds to the same medication in the same way, so the best treatment for Exudative vitreoretinopathy 6 depends on what is happening in the eye at that time.
Bevacizumab, ranibizumab, and aflibercept are medicines that can reduce leakage and slow abnormal blood vessel growth inside the eye. They are usually given as injections into the eye by a retina specialist, often as part of a broader treatment plan rather than the only treatment.
Corticosteroid eye injections or implants, such as triamcinolone or dexamethasone, are not standard treatment for Exudative vitreoretinopathy 6 but may be considered in selected situations if swelling or inflammation is also a problem. Their use is limited because they can raise eye pressure and increase the risk of cataracts.
There is no widely accepted daily pill or standard long-term medicine that treats the underlying genetic cause of Exudative vitreoretinopathy 6. For many living with this condition, medicines are usually supportive or used in specific eye findings rather than as a cure.
Genetic influences
When retinal problems affect sight from childhood or seem to appear across generations, it can help to know that exudative vitreoretinopathy 6 is a clearly genetic form of the condition. This subtype is linked to changes in the ZNF408 gene and is usually inherited in an autosomal dominant pattern, which means one altered copy from either parent can be enough to cause it. Even with the same gene change, people can have very different eye findings, from mild changes found on an eye exam to more serious leakage, scarring, or retinal detachment that can reduce vision. In some families, a parent may have only subtle symptoms while a child has earlier or more noticeable problems, which is one reason family eye history matters. Because exudative vitreoretinopathy 6 is inherited, genetic counseling and family testing can help clarify who else may be at risk and support earlier eye monitoring.
Is Exudative vitreoretinopathy 6 genetic?
Genetics are very important in exudative vitreoretinopathy 6, because it is usually caused by a change in the ZNF408 gene. These genetic variations can run in families and may help explain why eye findings and early symptoms of exudative vitreoretinopathy 6 vary so much.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct impact on health and simply reflect natural differences among people. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, one well-understood variant in a particular gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
People living with Exudative vitreoretinopathy 6 may need treatment plans tailored to how much the back of the eye is affected, and genetic testing can help confirm the diagnosis and show who in the family may also need eye checks. The underlying gene change affects how blood vessels form in the retina, so treatment usually focuses on the problems those vessels cause rather than on the gene itself. Genetics is only one factor, and doctors still rely on detailed eye exams and scans when deciding whether close monitoring, laser treatment, freezing treatment, injections that reduce abnormal vessel growth, or surgery for retinal detachment is the best next step. At this time, there are no well-established gene-based rules showing that people with Exudative vitreoretinopathy 6 respond differently to specific drugs than others. Even so, knowing the genetic cause can help families understand why follow-up matters, especially because early symptoms of Exudative vitreoretinopathy 6 can be easy to miss.
Interactions with other conditions
Many living with exudative vitreoretinopathy 6 are dealing mainly with vision problems, but other eye conditions can sometimes add to the picture. As the retina is pulled or damaged over time, people with exudative vitreoretinopathy 6 may also develop complications such as retinal detachment, bleeding inside the eye, cataracts, or glaucoma, which can further affect sight. Another important aspect is how it may link with other diseases: in babies born early, it can resemble retinopathy of prematurity, and doctors may need careful eye exams and family history to tell them apart. Exudative vitreoretinopathy 6 is not generally known to directly cause a wide range of unrelated body diseases, but some may find that early symptoms of exudative vitreoretinopathy 6 are first noticed during checks for another eye problem. Because severity varies a lot, regular follow-up with an eye specialist helps catch overlapping eye disease early and protect vision as much as possible.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Exudative vitreoretinopathy 6?
Other conditions that can look similar include an eye disease seen in babies born early, called retinopathy of prematurity, Coats disease, where abnormal blood vessels leak at the back of the eye, and some birth eye problems such as persistent fetal vasculature, where the eye does not finish developing in the usual way. Doctors may also consider other inherited retina problems or a retinal detachment from another cause, because these can also lead to poor vision, crossed eyes, a white-looking pupil, or similar changes during an eye exam.
History
Doctors first began to recognize this group of eye conditions when they saw children and adults with unusual blood vessel growth at the edges of the retina, sometimes with leaking, scarring, or retinal detachment, even though they had been born full term. In 1969, researchers described what is now called familial exudative vitreoretinopathy, noting that it could look like an eye problem usually linked to premature birth, but appeared in families without that history.
As medical science evolved, it became clear that this was not one single, uniform disorder. Some people had mild changes found only during an eye exam, while others developed serious vision problems early in life. For many, this helped explain why early symptoms of exudative vitreoretinopathy could be easy to miss at first, especially if one relative had only subtle vision changes and another had much more severe disease.
Later advances in retinal imaging gave doctors a much clearer view of what was happening in the back of the eye. They could better see the areas where normal blood vessel growth had stopped too soon, along with leakage and pulling on the retina. This made diagnosis more accurate and helped separate familial exudative vitreoretinopathy from other childhood retinal conditions that can appear similar.
Exudative vitreoretinopathy 6 is one of the later-recognized genetic forms within this broader condition. It was identified after researchers learned that different genetic changes could lead to a similar pattern of retinal disease, and that these forms could vary widely even within the same family. That shift mattered in everyday care: a child with poor vision, a parent with only mild night vision trouble, and a grandparent who never knew they were affected could all be part of the same medical story.
Today, the history of exudative vitreoretinopathy 6 reflects a broader change in medicine, from describing what doctors could see during an exam to understanding that there are several related forms of the disease. This has improved screening, family evaluation, and long-term eye care, even though the course can still differ a lot from one person to another.